Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Breast Cancer Research : BCR
|
March 16, 2001
Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency
A F Chambers, G N Naumov, S A Vantyghem, et al.
Journal of Cellular Biochemistry
|
June 22, 2000
Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met)
A B Tuck, B E Elliott, C Hota, et al.
The American Journal of Pathology
|
January 1, 1996
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma
A B Tuck, M Park, E E Sterns, et al.
Clinical & Experimental Metastasis
|
January 1, 1993
Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines
V L Morris, A B Tuck, S M Wilson, et al.
Current Molecular Medicine
|
March 20, 2002
The functional and clinical roles of osteopontin in cancer and metastasis
K A Furger, R K Menon, A B Tuck, et al.
In Vivo (Athens, Greece)
|
July 1, 1990
Comparison of metastatic properties of a variety of mouse, rat, and human cells in assays in nude mice and chick embryos
A F Chambers, S M Wilson, A B Tuck, et al.
Anticancer Research
|
June 6, 1998
MMP-2 expression is associated with, but not sufficient for, malignant conversion of murine LTA cells
J W Xuan, A B Tuck, S M Wilson, et al.
Oral Oncology
|
December 3, 2005
Osteopontin expression in salivary gland tumours
M R Darling, M Gauthier, L Jackson-Boeters, et al.
Archives of Pathology & Laboratory Medicine
|
June 1, 1997
Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas
A B Tuck, F P O'Malley, H Singhal, et al.
Oncogene
|
August 6, 1999
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells
A B Tuck, D M Arsenault, F P O'Malley, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Breast Cancer Research : BCR
|
March 16, 2001
Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency
A F Chambers, G N Naumov, S A Vantyghem, et al.
Journal of Cellular Biochemistry
|
June 22, 2000
Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met)
A B Tuck, B E Elliott, C Hota, et al.
The American Journal of Pathology
|
January 1, 1996
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma
A B Tuck, M Park, E E Sterns, et al.
Clinical & Experimental Metastasis
|
January 1, 1993
Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines
V L Morris, A B Tuck, S M Wilson, et al.
Current Molecular Medicine
|
March 20, 2002
The functional and clinical roles of osteopontin in cancer and metastasis
K A Furger, R K Menon, A B Tuck, et al.
In Vivo (Athens, Greece)
|
July 1, 1990
Comparison of metastatic properties of a variety of mouse, rat, and human cells in assays in nude mice and chick embryos
A F Chambers, S M Wilson, A B Tuck, et al.
Anticancer Research
|
June 6, 1998
MMP-2 expression is associated with, but not sufficient for, malignant conversion of murine LTA cells
J W Xuan, A B Tuck, S M Wilson, et al.
Oral Oncology
|
December 3, 2005
Osteopontin expression in salivary gland tumours
M R Darling, M Gauthier, L Jackson-Boeters, et al.
Archives of Pathology & Laboratory Medicine
|
June 1, 1997
Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas
A B Tuck, F P O'Malley, H Singhal, et al.
Oncogene
|
August 6, 1999
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells
A B Tuck, D M Arsenault, F P O'Malley, et al.
Page
of 3